Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23455,85,1.55 [0.75-3.20],0.2322528490017516
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23950,126,0.88 [0.48-1.62],0.6786111840427089
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23742,872,1.14 [0.90-1.43],0.2754251372453241
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23974,255,1.03 [0.67-1.58],0.899136823014004
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23291,2374,1.11 [0.97-1.29],0.135242144715412
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23515,1797,1.34 [1.14-1.57],0.0003451926487877
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23802,863,1.11 [0.88-1.40],0.3652880480728344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23908,37,2.80 [1.05-7.47],0.0391088351807832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22874,556,1.73 [1.31-2.30],0.0001396037371379
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22102,528,1.61 [1.20-2.15],0.001464855108868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22317,146,1.80 [1.03-3.16],0.0389776333176275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17806,1046,1.37 [1.11-1.70],0.0040328500406345
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22122,249,2.42 [1.62-3.61],1.7205528745005897e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23942,1003,1.06 [0.85-1.31],0.6202560683842399
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,24031,312,0.97 [0.66-1.43],0.8782438567963831
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23399,529,1.37 [1.02-1.84],0.0343167482263418
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23980,610,1.59 [1.21-2.08],0.0008449692891785
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23067,128,0.84 [0.45-1.54],0.5655442287052482
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24074,26,0.39 [0.10-1.48],0.165902480283653
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23907,537,1.62 [1.22-2.17],0.000967866908554
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23934,63,0.56 [0.24-1.33],0.1909019854243284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23986,151,1.46 [0.84-2.51],0.1761745659208348
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23971,136,1.49 [0.84-2.65],0.1695099071640776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23168,298,1.05 [0.71-1.57],0.7970258531892286
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23075,205,0.99 [0.61-1.60],0.9673939640380338
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23003,64,1.37 [0.59-3.20],0.4598926929435808
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24049,46,1.24 [0.46-3.31],0.6737647339032058
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24019,115,1.03 [0.55-1.95],0.920492559055382
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23943,39,2.09 [0.76-5.76],0.1559596877896796
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23949,45,0.44 [0.16-1.21],0.1107871926141855
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23815,276,1.18 [0.78-1.77],0.4398562952823219
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23996,64,1.49 [0.65-3.42],0.35003827469765
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23972,68,0.94 [0.41-2.16],0.8771773015004821
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10735,35,1.17 [0.36-3.86],0.7911230238439061
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23894,1014,1.05 [0.84-1.30],0.6714999525905236
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of meninges,24062,41,0.63 [0.22-1.84],0.4030359692566341
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24044,44,2.44 [0.95-6.29],0.0639965933353663
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24052,79,1.29 [0.60-2.73],0.514609563177053
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of ovary,13282,84,0.55 [0.26-1.15],0.1144880153408484
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24066,237,1.32 [0.85-2.05],0.2148828145906721
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,24063,178,0.98 [0.58-1.63],0.9237366107979104
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24007,47,0.57 [0.21-1.53],0.262191266440763
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,24069,153,1.30 [0.75-2.26],0.3427628020415735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,24035,249,0.81 [0.52-1.25],0.3389816784607267
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24003,479,0.91 [0.66-1.24],0.5471569993290373
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24066,266,1.01 [0.66-1.54],0.968428515529296
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Carcinoma in situ of breast,11384,76,0.58 [0.27-1.28],0.1791030468545053
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11422,85,0.57 [0.27-1.21],0.1428095045882773
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20765,30,1.27 [0.36-4.44],0.713141684639483
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20770,35,0.92 [0.29-2.97],0.8949034943393095
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24036,94,0.58 [0.29-1.19],0.1364013793358579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma, any site",24036,92,0.59 [0.29-1.20],0.1467521954239776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Leiomyoma of uterus,12715,355,1.05 [0.74-1.49],0.7940020475692375
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,17830,160,0.67 [0.38-1.16],0.1539407721032726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lymphoid leukaemia,20762,27,1.43 [0.39-5.34],0.590292481100539
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20861,126,1.32 [0.71-2.43],0.379231972426851
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20813,78,0.79 [0.36-1.74],0.5562933537689364
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11469,67,2.26 [1.03-4.98],0.0430614481903219
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20778,43,0.37 [0.13-1.06],0.0648004882893445
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20789,54,2.25 [0.95-5.35],0.0659334307106489
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20800,65,1.10 [0.47-2.59],0.8253907232004338
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11450,48,1.60 [0.61-4.19],0.3382903706359277
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20786,51,1.87 [0.75-4.67],0.1771590818630832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9673,340,1.07 [0.73-1.57],0.7193730705508328
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20816,81,1.12 [0.52-2.41],0.781567567718835
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20783,48,1.44 [0.54-3.81],0.4687007230647481
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20790,55,0.47 [0.18-1.20],0.1122511301669013
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi,23868,188,1.05 [0.64-1.73],0.848618718624842
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,24032,86,1.54 [0.74-3.18],0.2465089056047833
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanoma in situ,20746,40,0.49 [0.16-1.46],0.199520455573678
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20791,56,0.75 [0.29-1.89],0.537048491118875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20839,104,0.80 [0.41-1.59],0.5308124818236111
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20842,107,0.42 [0.22-0.81],0.0098570022899177
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20794,59,0.88 [0.36-2.18],0.7893943730574151
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Other benign neoplasms of skin,23914,129,0.83 [0.45-1.51],0.5363112784674957
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21298,563,1.18 [0.88-1.58],0.2578175513120553
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21327,592,1.22 [0.92-1.62],0.1698711961587655
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23829,256,1.26 [0.82-1.91],0.2880811026526693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22840,41,4.56 [1.96-10.60],0.0004315794294225
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23638,65,1.12 [0.48-2.60],0.788463003196338
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23373,1937,1.24 [1.06-1.45],0.0058731344538225
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23051,19,1.25 [0.27-5.87],0.7777801849984738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23762,29,1.03 [0.29-3.61],0.9634295753030124
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23683,884,1.46 [1.16-1.82],0.0010514098638468
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23683,884,1.46 [1.16-1.82],0.0010514098638468
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22848,49,2.19 [0.88-5.49],0.0931509957024675
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23827,795,1.14 [0.90-1.45],0.2766554325212982
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23827,94,3.15 [1.75-5.68],0.0001307260693263
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23618,45,0.99 [0.35-2.78],0.9885973466089506
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23611,38,1.38 [0.47-4.07],0.562653582444802
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23906,173,1.27 [0.76-2.13],0.3523523517115046
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24004,60,2.03 [0.89-4.62],0.0910131605116665
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23882,149,1.20 [0.69-2.09],0.5157554066457454
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23096,64,2.17 [0.98-4.82],0.0576550413081973
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20659,177,1.90 [1.16-3.12],0.0111613474688836
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22377,106,1.08 [0.55-2.09],0.828112765751996
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22398,127,1.92 [1.07-3.45],0.029843547224051
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20515,33,1.24 [0.37-4.13],0.7314603488889677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22336,64,1.11 [0.47-2.61],0.8097227216137186
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22014,124,1.63 [0.90-2.96],0.1052584169319109
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23945,144,0.91 [0.52-1.61],0.7560956820998694
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23848,47,0.98 [0.36-2.66],0.963540509060676
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23833,32,1.40 [0.43-4.58],0.582579131453526
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23718,1446,1.28 [1.07-1.53],0.0070968659925726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21545,1405,1.23 [1.03-1.48],0.0234677395645899
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20519,37,0.81 [0.26-2.55],0.7213201001082397
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22635,52,1.35 [0.54-3.40],0.5220370021444038
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20643,161,4.36 [2.87-6.64],6.298581282866188e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20537,55,0.65 [0.25-1.69],0.3804216477202615
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22566,2084,1.30 [1.12-1.51],0.0005657927364121
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20587,105,1.16 [0.59-2.28],0.662530352257954
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20824,342,2.20 [1.55-3.12],9.764123391047409e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23988,228,1.94 [1.27-2.98],0.0022440789016202
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23851,91,5.45 [3.31-8.95],2.3168218674093225e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20571,89,2.25 [1.12-4.53],0.0231543438523039
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20517,35,1.03 [0.32-3.28],0.9664432669830244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23700,1117,1.01 [0.83-1.24],0.8980729457284666
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20595,113,3.97 [2.34-6.74],3.099264508490233e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20616,134,4.46 [2.82-7.05],1.6014310881936832e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20820,338,1.41 [0.98-2.04],0.0675041461525544
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20537,55,3.26 [1.45-7.35],0.0044150024354378
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23846,86,5.93 [3.61-9.73],2.0284851741802297e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20748,266,1.60 [1.06-2.42],0.0256263734309735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20751,269,1.01 [0.66-1.54],0.9774618187679412
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21943,53,1.02 [0.40-2.61],0.9714972292562164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23465,2983,1.22 [1.07-1.38],0.0021390487905225
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22610,27,1.24 [0.35-4.39],0.7416167649572067
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22635,52,0.60 [0.23-1.56],0.2961042487725025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23913,1705,0.92 [0.78-1.09],0.3573171726068459
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23915,1701,0.92 [0.78-1.09],0.3267672396954215
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22615,32,1.56 [0.49-4.94],0.4465593094478659
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23796,1087,1.00 [0.81-1.23],0.9839264733192924
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21268,786,1.47 [1.15-1.87],0.0017695136508862
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24065,112,1.41 [0.75-2.64],0.2899909189835628
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23831,30,0.67 [0.19-2.33],0.5241118450242843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22787,78,1.54 [0.73-3.26],0.2540642757560657
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22806,97,0.49 [0.24-0.99],0.04534539868838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20593,111,1.81 [0.97-3.39],0.0627689779440321
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22499,107,1.39 [0.72-2.66],0.3269780356637176
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1502,60,1.57 [0.68-3.64],0.2954364065138321
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1596,165,0.82 [0.49-1.38],0.4599144075308079
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22429,37,1.45 [0.47-4.49],0.5159554308310444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1474,32,5.61 [2.03-15.45],0.0008587164815658
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23716,1324,1.12 [0.92-1.35],0.2572937518183524
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23861,60,1.80 [0.78-4.19],0.1696888080167778
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22131,241,1.53 [1.00-2.33],0.0495210707539523
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20840,358,1.34 [0.94-1.93],0.1067131131884005
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23995,152,1.62 [0.94-2.77],0.0815591104443998
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23410,47,1.27 [0.46-3.51],0.6467293016846847
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22970,695,0.99 [0.76-1.28],0.9246761609274962
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23456,93,1.43 [0.70-2.92],0.3238571513231516
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23391,28,1.66 [0.46-6.08],0.4414382198738996
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23458,95,2.24 [1.16-4.32],0.0160493117993625
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17109,810,1.02 [0.80-1.30],0.8872921636333624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,AV-block,21895,159,0.79 [0.45-1.38],0.4039427901808647
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24045,228,1.73 [1.12-2.68],0.0138906055346946
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16393,94,2.07 [1.07-4.00],0.0303877083577224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21853,117,0.82 [0.43-1.55],0.534133167703434
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21809,73,0.77 [0.34-1.74],0.5282060562789361
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24076,15,0.36 [0.06-2.20],0.2691729984504593
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,22206,470,1.08 [0.78-1.48],0.6476027024613802
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23434,1168,1.12 [0.92-1.37],0.2654137735338155
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22362,5292,1.00 [0.91-1.10],0.9416012970385648
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23073,160,1.53 [0.90-2.60],0.1199751310504318
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Endocarditis,21777,41,0.82 [0.28-2.45],0.7270422817536444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23968,456,1.36 [0.99-1.86],0.0557848377297829
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertension,22854,4304,1.07 [0.96-1.19],0.2089633387080885
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22863,4313,1.08 [0.97-1.20],0.1481733451923407
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23919,50,1.05 [0.40-2.75],0.926815287432756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18631,81,3.13 [1.62-6.02],0.0006417753576284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18591,41,16.05 [10.35-24.89],2.5954767385099294e-35
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypotension,23986,600,1.17 [0.89-1.55],0.2588497118536081
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23614,58,0.98 [0.40-2.42],0.9637397830782848
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23580,1305,1.08 [0.89-1.31],0.4296803289911299
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23881,274,1.02 [0.67-1.54],0.9381690483849504
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21919,183,1.50 [0.91-2.47],0.1079907655047231
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23852,525,1.32 [0.98-1.78],0.0647884565581106
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22704,429,1.34 [0.96-1.87],0.0823330509184075
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24026,106,1.04 [0.53-2.05],0.9036131822824344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24061,183,1.27 [0.77-2.09],0.3546134764721554
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22944,31,0.58 [0.17-2.05],0.40019442988646
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,23404,41,0.55 [0.19-1.61],0.2768150667821063
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21960,224,1.31 [0.83-2.07],0.244019888539181
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23422,59,1.65 [0.68-3.99],0.2681349800531108
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23489,126,1.73 [0.96-3.09],0.0664321535761924
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21849,113,1.33 [0.70-2.53],0.3855952709644421
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22976,63,0.38 [0.16-0.89],0.0266758090000146
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22958,45,0.87 [0.31-2.43],0.7968706012889243
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23394,33,1.47 [0.45-4.78],0.5183550540070075
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22995,82,0.44 [0.21-0.96],0.0380137197182356
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22253,517,1.49 [1.11-2.00],0.0087728956215714
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23428,42,1.46 [0.51-4.13],0.4785059075377764
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23674,311,1.47 [1.01-2.15],0.0450740411388895
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23681,139,2.32 [1.36-3.93],0.0018600037903332
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23569,208,0.68 [0.42-1.10],0.1158479180555783
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16514,215,1.42 [0.89-2.25],0.137718162107792
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23526,185,1.80 [1.11-2.93],0.0174861626563728
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23130,217,1.36 [0.86-2.16],0.1908382703892746
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23834,292,0.89 [0.59-1.33],0.5729362548545855
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24038,277,1.04 [0.69-1.56],0.8603466745897732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21887,151,0.93 [0.53-1.65],0.8170571598408117
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23678,136,2.36 [1.39-4.03],0.001600491424792
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23465,104,0.64 [0.33-1.27],0.2044236843647059
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23876,320,0.98 [0.67-1.43],0.9065889537549192
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23853,353,1.08 [0.75-1.56],0.6751486137882114
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23591,49,2.85 [1.18-6.92],0.0204351818494395
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23412,50,1.31 [0.49-3.47],0.5884774863044073
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23722,115,0.87 [0.46-1.66],0.6727233980827756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23480,153,0.97 [0.56-1.70],0.9264739685455796
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Varicose veins,23178,265,0.87 [0.57-1.32],0.5039109405169337
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23373,44,0.60 [0.21-1.69],0.3300357601227203
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23922,455,1.05 [0.76-1.45],0.749587094881329
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23939,332,0.96 [0.66-1.41],0.8351236952732862
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21429,1245,1.04 [0.85-1.26],0.7216012629543075
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Any mental disorder,23417,3233,1.04 [0.92-1.18],0.5135383405355547
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23886,387,0.90 [0.63-1.28],0.5674120529743247
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21659,1475,1.23 [1.03-1.47],0.0207091599423739
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20258,74,1.90 [0.90-3.99],0.0899109499608778
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Smoking dependency,23595,1343,0.95 [0.79-1.15],0.5968096040694086
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21736,1552,0.92 [0.77-1.09],0.3263973251238597
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Vascular dementia,23976,18,2.35 [0.61-9.05],0.2142654792318455
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,24075,64,0.93 [0.40-2.19],0.8698829612356093
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Bell's palsy,22606,66,0.91 [0.39-2.12],0.8205230145415204
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22963,423,1.01 [0.72-1.40],0.9692454036118876
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23759,172,0.88 [0.52-1.48],0.6186481534709776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24000,199,0.79 [0.48-1.29],0.3429906412512054
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23945,21,1.66 [0.39-7.00],0.4913534506075149
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24064,48,0.49 [0.18-1.31],0.1535892614002428
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23637,50,0.44 [0.16-1.16],0.0957397555625402
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Epilepsy,22716,229,0.63 [0.40-1.00],0.0485177358075275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23649,1162,1.15 [0.94-1.41],0.1601815996953469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24047,164,1.00 [0.59-1.71],0.9954047639348922
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23636,1452,1.08 [0.90-1.29],0.4039641647471342
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23751,47,0.72 [0.43-1.21],0.2166709674525752
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hemiplegia,23947,146,0.84 [0.48-1.48],0.5468064810115821
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23630,43,2.84 [1.11-7.27],0.0296421533577896
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24055,60,2.18 [0.96-4.96],0.0619956984358529
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22608,68,0.31 [0.14-0.71],0.0056044275686535
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22609,69,0.84 [0.37-1.93],0.6839275794969031
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Memory loss,23943,67,1.17 [0.51-2.68],0.711786295476125
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Migraine,22853,366,1.40 [0.99-1.99],0.0574459959121787
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23999,331,1.38 [0.96-2.00],0.0824419403149994
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,17481,89,0.93 [0.44-1.96],0.851483564434216
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23889,134,1.26 [0.70-2.26],0.4404944938385785
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23541,1001,1.00 [0.81-1.24],0.9827645251928292
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Neurological diseases,22803,2664,1.00 [0.88-1.15],0.9542412032087474
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23991,67,1.10 [0.48-2.52],0.8198844123190501
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22884,344,0.94 [0.65-1.36],0.7276031613425982
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24014,203,1.31 [0.81-2.10],0.266878816645037
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20071,282,1.06 [0.70-1.60],0.7765675335228196
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23639,52,1.22 [0.48-3.13],0.6775243317532139
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23691,104,1.96 [1.05-3.68],0.0358344867783254
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23954,71,1.31 [0.59-2.93],0.5071552606914247
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22624,84,0.85 [0.40-1.81],0.6810845960057874
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22543,56,1.52 [0.63-3.69],0.3505735921723542
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23971,384,1.10 [0.78-1.56],0.5785231370378693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22996,509,1.50 [1.12-2.02],0.0073124229472324
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,24062,74,0.57 [0.26-1.27],0.1669948212002892
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23642,55,0.41 [0.16-1.01],0.0535481375648524
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,24074,32,2.71 [0.95-7.74],0.0622637197996746
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23858,443,1.49 [1.08-2.04],0.0152575130973473
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23843,32,1.89 [0.60-5.97],0.2778300560834262
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24061,114,0.73 [0.38-1.39],0.3366275564033558
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22567,27,0.85 [0.23-3.18],0.8098003037343517
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24075,65,0.99 [0.42-2.30],0.973838957591854
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23964,17,2.47 [0.63-9.73],0.1957818438295442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23654,36,2.41 [0.85-6.85],0.0976016047802665
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23757,190,0.85 [0.52-1.39],0.511529614200624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24000,170,0.76 [0.45-1.29],0.3101004013629996
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23419,34,0.66 [0.20-2.14],0.4854545563156741
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23449,64,0.65 [0.27-1.55],0.3327740415285432
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23991,29,0.66 [0.19-2.38],0.5291102212068526
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23904,59,1.31 [0.55-3.12],0.5454598334115172
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1477,35,5.68 [2.15-15.02],0.00046774204068
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1747,72,1.52 [0.74-3.10],0.2501074856746572
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23692,74,0.95 [0.43-2.10],0.8906118595779833
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23970,546,0.76 [0.57-1.02],0.069678955122215
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23804,419,0.93 [0.66-1.29],0.6508440755950198
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23506,121,0.72 [0.39-1.34],0.3048987574849333
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23995,428,1.14 [0.82-1.58],0.4472154208388917
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24068,50,2.43 [1.02-5.81],0.0457927376608907
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23926,359,1.04 [0.73-1.49],0.8166281340398212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24039,194,1.21 [0.75-1.96],0.4332864328647305
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24019,120,0.99 [0.53-1.85],0.9869300838579396
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23400,15,2.58 [0.54-12.39],0.2352899358592245
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23411,26,1.27 [0.34-4.80],0.7267120243935603
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23415,30,1.45 [0.44-4.84],0.543780747207387
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24033,337,0.88 [0.61-1.27],0.4934369461110046
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23777,81,0.76 [0.35-1.61],0.4688354496671615
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23588,21,3.90 [1.20-12.67],0.0234780530132265
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23907,62,0.95 [0.40-2.24],0.9016360588941228
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23979,134,1.33 [0.75-2.38],0.3289527933987488
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23714,147,1.13 [0.65-1.99],0.6601721702292265
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23969,70,1.44 [0.65-3.20],0.3641245790778666
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23918,222,0.77 [0.49-1.21],0.2586366756440539
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23715,97,1.33 [0.67-2.61],0.4129383935134395
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23456,952,0.97 [0.78-1.21],0.7815433291145844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23957,112,1.37 [0.73-2.57],0.3332561408750077
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24054,101,1.49 [0.77-2.89],0.230829371746636
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23619,234,1.02 [0.65-1.59],0.9453369757044684
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23880,35,1.11 [0.35-3.49],0.8622236891515335
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24052,34,1.31 [0.41-4.13],0.6469987960210477
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23421,36,1.07 [0.35-3.33],0.9015928161526156
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23488,103,0.76 [0.38-1.50],0.4290087954189299
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23481,57,0.60 [0.24-1.49],0.2727233944764178
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23618,51,1.32 [0.51-3.40],0.5628915594047325
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23471,47,0.80 [0.29-2.18],0.6586670652466365
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23741,45,1.59 [0.60-4.24],0.3517549903798014
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23776,80,1.33 [0.63-2.81],0.4573399468760092
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23460,75,0.96 [0.44-2.09],0.9112947487335732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23532,108,0.71 [0.36-1.39],0.3225657682901581
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23453,29,0.54 [0.15-1.90],0.333185274149219
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23229,725,1.02 [0.79-1.32],0.861106641922519
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23428,43,0.45 [0.16-1.26],0.1283723846916525
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23889,271,1.24 [0.82-1.86],0.3129215541615486
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23650,32,0.93 [0.27-3.16],0.90559065818776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23725,107,1.02 [0.53-1.97],0.9445665263883212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23895,55,1.09 [0.44-2.70],0.860157108834585
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24035,82,1.03 [0.48-2.20],0.934527589059714
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23964,124,1.73 [0.97-3.11],0.0646797365846705
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23891,51,1.11 [0.43-2.86],0.8343749805565914
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23889,49,0.60 [0.22-1.59],0.3023095026999007
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23993,477,1.29 [0.94-1.75],0.1099393640706106
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23810,294,1.14 [0.76-1.69],0.5328903374512499
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23602,86,0.96 [0.46-2.00],0.9192513596004488
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23585,69,0.99 [0.44-2.26],0.9867425451826076
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23815,67,0.88 [0.38-2.01],0.7541109699946416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23957,209,1.39 [0.88-2.20],0.1592230221277649
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23803,55,2.13 [0.91-4.98],0.0797411268230867
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza,22925,70,2.57 [1.23-5.38],0.0122460638927084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22924,69,2.59 [1.23-5.44],0.0121737141846384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17785,115,1.30 [0.68-2.46],0.4274118569644999
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23955,279,0.69 [0.46-1.05],0.0816973331594253
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19089,1550,1.07 [0.90-1.28],0.4419503445365449
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19190,1520,1.06 [0.89-1.26],0.5274147123290489
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23823,88,1.95 [0.99-3.82],0.0531374671931175
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22907,52,2.54 [1.10-5.85],0.0284538575554435
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,21390,153,1.40 [0.82-2.40],0.2230991284636355
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21272,35,0.37 [0.12-1.17],0.0912557951498316
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23303,2066,1.05 [0.90-1.22],0.5275212885417425
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22775,60,0.52 [0.21-1.27],0.1514976575075762
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22859,144,1.26 [0.71-2.21],0.4292398411890509
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23984,636,0.92 [0.70-1.21],0.5496194812479396
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22832,117,0.68 [0.36-1.31],0.251021033451653
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22380,3731,1.07 [0.95-1.20],0.2500364129760116
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23049,334,0.84 [0.57-1.22],0.3578680691672038
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Early onset COPD,23802,454,0.87 [0.63-1.21],0.4138765647497099
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Emphysema,21402,165,0.85 [0.49-1.45],0.5405069265746842
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22951,99,0.94 [0.47-1.88],0.8535683069796105
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23912,1057,1.26 [1.02-1.55],0.0296612379145973
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22973,121,1.07 [0.57-1.99],0.8326138398271202
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Later onset COPD,22787,182,1.01 [0.61-1.68],0.9649593037539284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24070,134,0.85 [0.47-1.54],0.5885304000752922
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Nasal polyp,22821,106,1.26 [0.65-2.44],0.4958413611069389
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23883,559,1.22 [0.92-1.63],0.1733532931324604
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23921,1102,1.21 [0.98-1.48],0.0732590581770468
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23502,787,0.84 [0.66-1.08],0.1693276757759738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,22851,32,0.38 [0.11-1.30],0.1235934892551965
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24019,179,1.98 [1.22-3.20],0.0053729658443049
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24006,751,1.35 [1.06-1.72],0.0164128167347645
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural effusion,23347,528,1.12 [0.83-1.50],0.4726747872157389
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural plaque,22868,49,0.89 [0.33-2.39],0.8129327036780912
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23727,872,1.19 [0.95-1.50],0.1355660861820188
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24052,116,1.05 [0.55-1.97],0.8890548144456853
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumothorax,22876,57,0.48 [0.19-1.20],0.1172360706042293
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pollen allergy,24049,242,0.73 [0.47-1.14],0.16973315330872
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23876,36,6.28 [2.98-13.22],1.344093377395646e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17701,31,0.82 [0.24-2.82],0.748547722592429
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23863,539,1.18 [0.88-1.58],0.2746833862628008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22994,279,0.69 [0.46-1.05],0.0850673737093992
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,23020,165,1.20 [0.71-2.05],0.4965586295781243
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23840,141,1.07 [0.60-1.88],0.8282498231040908
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13844,86,1.00 [0.47-2.12],0.9990825524956248
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18402,54,2.06 [0.82-5.17],0.122847424098254
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23899,132,0.83 [0.45-1.52],0.5497532660789948
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute gastritis,19218,58,1.19 [0.49-2.91],0.7037111563726153
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22656,148,0.81 [0.46-1.44],0.4783826582797424
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23671,60,3.11 [1.47-6.59],0.0030498284346845
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23396,77,1.46 [0.68-3.16],0.3358393016992728
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,19476,316,1.14 [0.77-1.68],0.5033904155892361
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22559,51,3.63 [1.67-7.90],0.0011802258889732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23720,51,3.66 [1.67-8.01],0.0011580241711645
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholecystitis,22665,157,0.85 [0.49-1.48],0.5663909318482502
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,23335,827,0.93 [0.73-1.18],0.5459013751992535
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,19380,220,0.75 [0.47-1.20],0.2290055194259698
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22546,38,1.68 [0.58-4.91],0.3424349998317021
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23945,76,0.82 [0.37-1.80],0.618105436685993
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Coeliac disease,22829,100,0.52 [0.26-1.04],0.0647304187043261
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22701,49,0.69 [0.26-1.86],0.468329089502942
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23908,180,1.05 [0.63-1.76],0.8467432319239538
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Constipation,23883,1019,1.08 [0.87-1.34],0.4820194744461508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn disease,22736,84,0.82 [0.39-1.75],0.6100090049395308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23770,56,0.77 [0.31-1.93],0.5783856671702106
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22730,78,0.91 [0.42-1.99],0.8113511063580727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Dental caries,23341,226,0.88 [0.56-1.38],0.5683288762903377
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22226,1574,0.99 [0.83-1.18],0.914921110135226
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23936,169,0.76 [0.45-1.30],0.3198637337592132
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of liver,23971,652,1.25 [0.96-1.63],0.1024967021414695
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22538,3378,0.93 [0.82-1.05],0.2188837505037776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23649,534,0.86 [0.64-1.16],0.3378876932652379
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24004,393,1.33 [0.95-1.87],0.096787999846876
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23232,117,0.72 [0.38-1.36],0.3114298582866694
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23093,61,0.91 [0.38-2.18],0.8254816481421576
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23830,1101,1.18 [0.96-1.45],0.1121946464772263
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,23095,106,1.20 [0.62-2.33],0.5896973440656958
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23625,1117,0.95 [0.77-1.16],0.6021611768712218
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20487,2139,1.20 [1.03-1.39],0.017867853578823
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19287,127,1.01 [0.55-1.87],0.9694296141149348
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24010,99,0.82 [0.41-1.65],0.5808034847915862
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23960,72,0.99 [0.44-2.22],0.9798880968542946
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23413,94,0.98 [0.48-1.97],0.9453103383741398
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18504,156,1.02 [0.58-1.79],0.9390689710083436
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19614,454,0.78 [0.56-1.07],0.1275100227022472
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,19414,254,0.71 [0.46-1.09],0.1147022462279111
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21131,1971,1.00 [0.85-1.16],0.9576918615043616
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19526,366,0.75 [0.52-1.08],0.1240528142834078
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19580,6972,0.97 [0.89-1.05],0.4320723976569411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,GI-bleeding,23608,879,1.30 [1.03-1.63],0.0258733473020005
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23175,60,0.83 [0.34-2.00],0.6738814349140794
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19144,1112,0.91 [0.74-1.13],0.3932534128632718
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23365,46,1.02 [0.37-2.81],0.9729341741213646
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Hernia,23031,2379,0.93 [0.81-1.08],0.3407198735141408
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impacted teeth,23970,67,1.01 [0.44-2.33],0.979304418711756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,18380,32,2.75 [0.90-8.43],0.076902535471063
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,21249,597,0.73 [0.55-0.98],0.0368608092024882
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20723,71,0.92 [0.40-2.14],0.8533908481821284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18412,64,0.66 [0.28-1.58],0.3500413743850481
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22850,121,0.72 [0.38-1.35],0.3044597141906559
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18854,506,0.83 [0.61-1.14],0.2490922169680301
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24050,342,1.38 [0.96-1.98],0.0840466197591079
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23263,611,1.29 [0.98-1.69],0.0721183362569554
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23421,769,1.24 [0.97-1.58],0.0862911510437411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19281,121,1.12 [0.60-2.08],0.7278556091206274
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophagitis,19585,425,1.08 [0.77-1.50],0.6616944585644895
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24035,116,1.18 [0.63-2.23],0.6021058438572342
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20695,43,0.33 [0.12-0.93],0.0364430793440459
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19483,1135,1.11 [0.91-1.37],0.3090711144959114
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22680,172,1.45 [0.87-2.42],0.1502396280090165
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22649,141,0.93 [0.52-1.66],0.8148198281728566
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,19680,1332,1.05 [0.87-1.27],0.6318604992464144
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22615,4267,1.08 [0.97-1.20],0.1598387492667695
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23093,169,0.82 [0.48-1.39],0.4529598233733584
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23844,525,1.29 [0.96-1.73],0.0885580066277579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19640,480,0.99 [0.72-1.35],0.9298491958063804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22580,72,1.91 [0.88-4.13],0.1004409908555333
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23956,345,1.15 [0.80-1.66],0.4588008868234758
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19833,673,0.87 [0.67-1.14],0.3182370065988358
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23622,893,1.31 [1.05-1.64],0.0189825088445655
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23266,151,0.82 [0.47-1.44],0.4932918720618774
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19411,1063,1.05 [0.85-1.30],0.626954222641411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20701,1541,1.06 [0.89-1.26],0.5327713284753212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23391,72,1.02 [0.45-2.29],0.961336332851808
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23321,669,1.23 [0.94-1.59],0.1292935596351094
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18560,212,0.81 [0.50-1.30],0.3758068858342646
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23945,85,1.11 [0.53-2.32],0.7878928242472569
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18660,312,0.79 [0.53-1.17],0.2386462965374648
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22852,123,0.92 [0.49-1.71],0.7911596177232401
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24065,53,0.52 [0.20-1.33],0.17190167904843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23126,109,0.73 [0.38-1.43],0.3614367199853373
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Toxic colitis,22674,22,2.06 [0.53-8.02],0.2979303178749858
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19328,168,0.74 [0.43-1.26],0.2647066635362312
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22782,130,1.30 [0.71-2.35],0.3926593635455412
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22765,113,1.10 [0.57-2.09],0.7788123453542556
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20889,237,0.90 [0.57-1.42],0.6493471054186071
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18439,91,0.62 [0.30-1.28],0.1966890772201815
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ventral hernia,20857,205,1.49 [0.93-2.39],0.0932072733544437
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Volvulus,18406,58,0.54 [0.22-1.35],0.1872672568935852
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24035,135,0.84 [0.46-1.52],0.5645181858958562
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23842,73,1.94 [0.91-4.11],0.0843939492204948
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22771,127,0.65 [0.35-1.21],0.1738821825321394
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23512,489,1.06 [0.78-1.45],0.7132624270357444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23200,177,1.25 [0.74-2.09],0.4009779870311397
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22795,151,1.36 [0.79-2.35],0.2725686221125543
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23844,202,1.05 [0.65-1.71],0.8300482498372255
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23985,343,0.96 [0.66-1.39],0.8284119710853746
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23682,40,0.85 [0.29-2.55],0.775592172076041
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22785,2249,0.88 [0.76-1.02],0.0839844610276379
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23672,375,0.73 [0.51-1.04],0.0791741440049202
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23561,264,0.63 [0.41-0.96],0.0325818895074481
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23721,698,1.09 [0.84-1.42],0.4959972252783478
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24064,41,0.79 [0.27-2.32],0.6725142205786043
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22697,53,0.62 [0.24-1.58],0.3115655710022783
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23334,37,0.87 [0.28-2.69],0.8093902371751538
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23838,196,1.11 [0.68-1.81],0.6815133561698301
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22909,265,0.84 [0.54-1.28],0.4110006027749306
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22678,34,0.71 [0.41-1.24],0.2343860680936023
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23999,64,1.56 [0.68-3.57],0.2983971087670556
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23140,117,0.71 [0.38-1.36],0.3030206828177441
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23902,133,0.83 [0.46-1.51],0.5471321828374691
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23666,24,0.91 [0.22-3.80],0.8996373163791502
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22690,46,0.41 [0.15-1.14],0.0870314778441442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23622,978,0.84 [0.67-1.04],0.1115499259592843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22937,293,0.89 [0.59-1.33],0.5715079935007641
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22682,38,0.69 [0.40-1.20],0.1906787993886721
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24003,234,1.00 [0.64-1.57],0.9978699211362498
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23697,55,1.59 [0.66-3.84],0.2975862339868628
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23960,191,1.09 [0.67-1.79],0.7222751485823081
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24049,149,0.84 [0.48-1.47],0.5377388336963675
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22750,106,0.67 [0.34-1.31],0.2369317137783043
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22811,167,1.05 [0.61-1.79],0.8674542761823607
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24044,144,0.84 [0.47-1.49],0.5518419088649422
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22760,116,0.65 [0.34-1.23],0.1835520170365566
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24043,108,1.27 [0.66-2.42],0.4765152413733678
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21091,115,0.59 [0.31-1.12],0.1078039689392784
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22441,4070,0.99 [0.89-1.11],0.8959600570888903
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21247,2876,0.85 [0.75-0.97],0.0142354705775182
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21062,86,0.97 [0.46-2.04],0.939218687620747
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21570,139,1.48 [0.84-2.61],0.1724762391654686
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21572,141,0.57 [0.32-1.02],0.0570891294502127
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23872,105,0.85 [0.43-1.65],0.6229921940570705
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21474,43,0.64 [0.23-1.80],0.3976698793434499
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19041,670,0.74 [0.57-0.97],0.029446823010156
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24021,114,0.94 [0.50-1.79],0.8553785636213979
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21680,249,1.17 [0.76-1.79],0.4793596236045933
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21020,5462,0.97 [0.88-1.06],0.4656232673548256
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22847,97,2.85 [1.55-5.25],0.0007459708855962
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21078,102,0.93 [0.47-1.85],0.8351913213165914
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21522,546,0.93 [0.69-1.25],0.6390404571803813
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23278,1847,0.99 [0.85-1.16],0.9396539171119336
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21179,203,1.03 [0.63-1.67],0.9077254980031096
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21236,260,0.85 [0.56-1.30],0.4628286723516025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21108,132,1.07 [0.59-1.95],0.8184218134941216
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23598,32,0.71 [0.41-1.22],0.2147384726847494
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19507,1136,0.85 [0.69-1.05],0.133153817639888
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18714,343,3.13 [2.34-4.20],2.14151577887832e-14
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24027,333,3.24 [2.38-4.41],7.0237383379992e-14
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18439,68,1.01 [0.43-2.33],0.9865051076257308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18679,308,0.77 [0.52-1.14],0.1976205567560666
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21264,288,0.87 [0.58-1.30],0.4899195075651006
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19038,667,0.93 [0.71-1.22],0.5867466276449376
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21455,24,1.77 [0.46-6.78],0.4063957078171503
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21928,497,1.21 [0.89-1.63],0.2223631722061499
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21684,253,0.85 [0.55-1.31],0.4614123881970998
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18990,619,0.94 [0.71-1.24],0.661845225777446
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21043,67,0.91 [0.40-2.11],0.8344452155283271
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21031,55,0.54 [0.21-1.36],0.1905807027862157
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22803,53,2.17 [0.92-5.10],0.0758450764349564
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23783,1033,1.05 [0.85-1.30],0.6562182547345217
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23331,581,0.88 [0.66-1.17],0.3722716292194895
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23969,307,0.82 [0.55-1.20],0.3056548102303569
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19925,1554,0.93 [0.78-1.10],0.3929847027416067
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18439,68,0.92 [0.40-2.13],0.8432160337506793
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21045,69,1.07 [0.47-2.44],0.8713912902199386
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18396,25,2.10 [0.59-7.49],0.2526982752752375
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18474,103,0.56 [0.28-1.11],0.099039876121593
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22959,209,1.10 [0.68-1.76],0.7011834384076696
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22974,224,0.99 [0.63-1.56],0.9649749379172804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24039,74,0.65 [0.29-1.45],0.2954673578158886
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22820,1389,1.02 [0.85-1.23],0.8208788242655636
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21083,107,0.65 [0.33-1.26],0.1997491077315072
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18483,112,0.92 [0.48-1.77],0.8044639487425467
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21989,558,0.97 [0.73-1.30],0.861698283449256
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20174,1803,0.97 [0.83-1.15],0.755418320130154
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23617,51,0.47 [0.18-1.22],0.1190392439106527
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24051,68,1.93 [0.88-4.21],0.1004113486869609
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21046,70,1.06 [0.47-2.41],0.8812340277987523
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21949,973,0.98 [0.78-1.22],0.8344710369552295
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21036,60,0.82 [0.33-2.03],0.6682069793046835
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19368,997,1.00 [0.80-1.24],0.9648197181599368
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22845,95,0.85 [0.42-1.72],0.6493269856817713
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21035,59,0.85 [0.35-2.10],0.7290579640174719
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21531,100,0.68 [0.34-1.35],0.2722116990729875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21324,348,1.41 [0.98-2.01],0.0623875381311727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23755,189,1.21 [0.74-1.97],0.453508895865668
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21854,423,1.15 [0.83-1.60],0.3945466845226134
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23978,292,0.75 [0.51-1.12],0.1662834691643726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24058,34,0.70 [0.22-2.28],0.5556122154286212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21162,186,1.28 [0.78-2.10],0.3221317278736032
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19291,545,1.07 [0.80-1.43],0.6644010433956015
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21416,440,0.94 [0.68-1.30],0.6870540427366261
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21127,151,1.02 [0.58-1.80],0.9396693659796848
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18405,34,1.23 [0.38-4.00],0.7311233903586318
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19936,1565,1.21 [1.02-1.44],0.0294571617507374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18769,398,1.02 [0.72-1.44],0.9209001152138536
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23644,78,1.41 [0.66-3.01],0.3720561979410618
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24009,44,1.11 [0.40-3.09],0.8463806437356072
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22676,26,0.91 [0.24-3.44],0.8849049047629354
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18441,70,1.92 [0.88-4.20],0.1009345667684844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21511,80,0.90 [0.42-1.93],0.7852171923654846
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18681,310,0.76 [0.51-1.13],0.1760069848232437
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21216,240,0.92 [0.59-1.43],0.7054192021759249
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21623,192,1.66 [1.04-2.66],0.0346474926433363
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21522,91,0.66 [0.32-1.36],0.264109284397223
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20341,44,0.66 [0.23-1.87],0.4329176591694729
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24061,37,0.93 [0.30-2.87],0.9050221390122184
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21502,526,0.79 [0.58-1.07],0.1236261357561449
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23643,77,1.03 [0.48-2.21],0.9444488592534152
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23125,2149,0.92 [0.80-1.07],0.2863430374435509
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21076,100,0.81 [0.40-1.61],0.5420819959518173
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21749,318,1.28 [0.88-1.87],0.2029312033043585
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22828,164,0.69 [0.40-1.18],0.1758532734682611
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21563,132,1.33 [0.74-2.37],0.3377849287081795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22377,946,1.01 [0.81-1.26],0.9443666782655272
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22051,620,1.01 [0.77-1.32],0.959711968403966
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21015,39,1.09 [0.36-3.25],0.8803712145518464
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23709,143,1.17 [0.67-2.04],0.5824649480175513
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21115,139,0.50 [0.28-0.90],0.020669553091631
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21029,53,0.74 [0.29-1.89],0.528227804698155
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18404,33,1.09 [0.32-3.64],0.8929798493989961
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23615,749,2.13 [1.67-2.71],7.708500017131444e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9771,63,2.51 [1.16-5.44],0.0197959618082434
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13003,72,1.08 [0.49-2.39],0.8447164070595006
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23817,272,1.44 [0.96-2.17],0.0782564677370578
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23599,54,0.93 [0.36-2.41],0.8856994860684515
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23428,562,6.09 [5.00-7.42],7.7587680195098e-72
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23915,19,13.01 [5.75-29.46],7.539921836538128e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23921,160,1.19 [0.70-2.05],0.5173951806744278
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,22124,136,0.84 [0.46-1.52],0.5623245452667598
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,22908,42,20.35 [13.26-31.24],3.24529319551504e-43
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10406,987,0.99 [0.79-1.23],0.8998924175181691
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13105,174,1.13 [0.68-1.87],0.6494198379580032
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9822,114,2.08 [1.15-3.78],0.0156554303957887
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10039,331,0.82 [0.56-1.21],0.3196738133231074
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10081,373,1.05 [0.74-1.49],0.7876080745929034
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20282,3695,1.18 [1.05-1.32],0.0054525755569165
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23954,58,3.81 [1.82-8.00],0.0004048282232368
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9488,69,1.15 [0.49-2.69],0.7409780513392776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22790,195,2.37 [1.48-3.81],0.0003333544376172
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10075,656,0.94 [0.71-1.24],0.6553027892083445
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12983,207,1.41 [0.89-2.23],0.1428043031434197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9512,93,0.91 [0.44-1.87],0.7970622878560418
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,13003,106,0.82 [0.42-1.59],0.5508742719783672
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9966,258,0.81 [0.52-1.24],0.3279004199556429
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22042,54,1.22 [0.48-3.09],0.680265419071757
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10931,1223,1.07 [0.88-1.30],0.476454081752806
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9466,47,0.67 [0.24-1.86],0.4374423925787585
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9795,87,0.92 [0.44-1.92],0.8289159375042112
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24065,35,0.74 [0.24-2.35],0.613802885800816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24070,42,0.63 [0.22-1.82],0.3973158934660845
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23309,1321,1.09 [0.90-1.32],0.3646090694577624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22399,411,1.03 [0.74-1.45],0.8486584529335731
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12986,55,0.81 [0.33-2.04],0.6612081338844116
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24028,267,2.65 [1.81-3.86],4.601598977658684e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9556,137,1.12 [0.61-2.05],0.7127067736805446
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9523,104,1.12 [0.56-2.24],0.7436097380203486
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9481,62,0.82 [0.34-2.00],0.6604846294166975
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24041,50,5.29 [2.68-10.46],1.66206145000303e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22963,975,1.19 [0.95-1.47],0.123215927636599
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12883,107,1.53 [0.81-2.88],0.1892357530324087
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9777,69,1.41 [0.63-3.14],0.4023704366414898
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9912,204,1.26 [0.78-2.01],0.342819726588727
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9762,54,0.44 [0.17-1.11],0.0803424667744086
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9803,95,1.30 [0.65-2.58],0.4612427602047113
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22820,225,2.54 [1.65-3.92],2.2707896906078844e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23853,92,4.45 [2.53-7.82],2.035120486786065e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9858,150,0.78 [0.44-1.36],0.3754065326794324
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9776,68,0.66 [0.28-1.52],0.3247552072495792
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10074,366,1.22 [0.85-1.73],0.2775329146508383
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9765,57,1.29 [0.53-3.14],0.5710266004819196
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10031,323,1.45 [1.00-2.10],0.0476425953638181
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23936,40,3.38 [1.31-8.72],0.0118555220789724
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9514,95,0.94 [0.45-1.94],0.860286540342303
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23912,1317,2.41 [2.01-2.88],5.719191712721641e-22
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22719,124,2.47 [1.39-4.39],0.0021516461782994
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22925,59,4.04 [1.86-8.76],0.0004028296509862
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23606,61,0.86 [0.35-2.10],0.7324992408683227
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22133,145,1.15 [0.65-2.05],0.626540753659564
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23875,330,1.30 [0.90-1.89],0.165486484480832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9793,85,1.16 [0.56-2.41],0.6910441479910212
